Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000012831 | SCV000487155 | pathogenic | Fanconi anemia complementation group C | 2016-10-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001221363 | SCV001393403 | pathogenic | Fanconi anemia | 2019-08-18 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 2 of the FANCC gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be homozygous or in combination with another FANCC variant in individuals affected with Fanconi anemia and to segregate with disease in families (PMID: 20869034). ClinVar contains an entry for this variant (Variation ID: 12051). Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 20869034). Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FANCC are known to be pathogenic (PMID: 17924555). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001588811 | SCV001824150 | pathogenic | not provided | 2019-08-07 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 22588721, 30355602, 28146134, 20869034, 25236480, 22426302, 25525159) |
Al Jalila Children’s Genomics Center, |
RCV001588811 | SCV002818196 | pathogenic | not provided | 2022-12-17 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001588811 | SCV004224295 | pathogenic | not provided | 2023-02-15 | criteria provided, single submitter | clinical testing | PP1_strong, PP5, PM2, PS3, PS4_moderate, PVS1_strong |
OMIM | RCV000012831 | SCV000033071 | pathogenic | Fanconi anemia complementation group C | 2010-10-08 | no assertion criteria provided | literature only | |
Leiden Open Variation Database | RCV000012831 | SCV001365309 | pathogenic | Fanconi anemia complementation group C | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. |
Gene |
RCV000012831 | SCV001737416 | not provided | Fanconi anemia complementation group C | no assertion provided | literature only | ||
Al Jalila Children’s Genomics Center, |
RCV000012831 | SCV001984200 | pathogenic | Fanconi anemia complementation group C | 2020-08-18 | flagged submission | clinical testing | |
Natera, |
RCV001221363 | SCV002081302 | pathogenic | Fanconi anemia | 2017-03-17 | no assertion criteria provided | clinical testing |